Arndt Vogel, Prof. Dr.

Trials

Studies that name Arndt Vogel, Prof. Dr. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:33 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05489250 · The PLATON Network

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · terminated · Hepatocellular Cancer, Cholangiocarcinoma, Gallbladder Cancer · principal investigator
• Ph2
  NCT05101629 · Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · completed · Hepatocellular Carcinoma · principal investigator
• Ph2
  NCT04522544 · Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · active not recruiting · Hepatocellular Carcinoma Non-resectable, HCC · principal investigator
• Ph2
  NCT04511455 · Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · completed · Hepatocellular Carcinoma Non-resectable, Metastatic Hepatocellular Carcinoma · principal investigator
• Ph2
  NCT03473574 · Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients

  AIO-Studien-gGmbH · completed · Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.